GPC3-specific NK-92/9.28.z cells are functional, produced higher levels of IFN-γ and effectively lysed GPC3+ HCC cell lines in vitro, and significantly reduced the tumor growth of GPC3+ HHC in vivo [249]. The gene discussed is IFNG; the disease is hepatocellular carcinoma.